BARAULT, LUDOVIC
 Distribuzione geografica
Continente #
NA - Nord America 2.343
EU - Europa 2.309
AS - Asia 1.513
SA - Sud America 37
OC - Oceania 32
AF - Africa 23
Continente sconosciuto - Info sul continente non disponibili 4
Totale 6.261
Nazione #
US - Stati Uniti d'America 2.251
CN - Cina 1.040
IT - Italia 779
RU - Federazione Russa 488
GB - Regno Unito 154
DE - Germania 140
FR - Francia 116
SE - Svezia 106
JP - Giappone 104
IE - Irlanda 84
ES - Italia 79
CA - Canada 68
HK - Hong Kong 63
IN - India 63
TW - Taiwan 57
FI - Finlandia 48
KR - Corea 46
PL - Polonia 42
UA - Ucraina 40
NL - Olanda 37
VN - Vietnam 35
AU - Australia 31
BE - Belgio 31
DK - Danimarca 30
CH - Svizzera 29
MX - Messico 23
AT - Austria 20
BR - Brasile 20
SG - Singapore 18
GR - Grecia 17
AM - Armenia 16
PT - Portogallo 15
HU - Ungheria 13
IL - Israele 13
NO - Norvegia 10
TR - Turchia 10
RO - Romania 9
MY - Malesia 7
AR - Argentina 6
BN - Brunei Darussalam 6
DZ - Algeria 6
IR - Iran 6
ZA - Sudafrica 6
BA - Bosnia-Erzegovina 5
CO - Colombia 5
CZ - Repubblica Ceca 5
AE - Emirati Arabi Uniti 4
EG - Egitto 4
ID - Indonesia 4
PH - Filippine 4
TN - Tunisia 4
BY - Bielorussia 3
ET - Etiopia 3
SA - Arabia Saudita 3
TH - Thailandia 3
BG - Bulgaria 2
CL - Cile 2
EC - Ecuador 2
EU - Europa 2
HR - Croazia 2
JO - Giordania 2
KW - Kuwait 2
KZ - Kazakistan 2
LB - Libano 2
LU - Lussemburgo 2
A1 - Anonimo 1
A2 - ???statistics.table.value.countryCode.A2??? 1
BD - Bangladesh 1
HN - Honduras 1
LK - Sri Lanka 1
NZ - Nuova Zelanda 1
PE - Perù 1
PK - Pakistan 1
RS - Serbia 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
VE - Venezuela 1
Totale 6.261
Città #
Ann Arbor 378
Beijing 212
Chandler 168
Shanghai 137
Torino 117
Fairfield 102
Redwood City 102
Guangzhou 92
Dublin 79
Houston 76
Woodbridge 69
Ashburn 65
Milan 62
Seattle 62
Hangzhou 57
Nanjing 55
Wilmington 55
Cambridge 54
Dearborn 52
Nyköping 49
Rome 43
Jacksonville 35
Medford 34
Tokyo 32
Taipei 31
Pisa 29
Villeurbanne 27
Turin 26
London 25
Wuhan 25
New York 23
Tianjin 23
Princeton 22
Warsaw 21
Boston 20
Lappeenranta 20
Galveston 19
Central 18
Shenyang 18
Fremont 17
Harbin 17
Los Angeles 17
Chengdu 16
Zhengzhou 15
Barcelona 14
Changsha 14
Dong Ket 14
Yerevan 13
Brussels 12
Duncan 12
Hong Kong 12
Ottawa 12
Palermo 12
Rotterdam 12
Toronto 12
Central District 11
Helsinki 11
Melbourne 11
Paris 11
Serio 11
Buffalo 10
Chicago 10
Jinan 10
Munich 10
Odense 10
Phoenix 10
San Diego 10
Bologna 9
Bolzano 9
Chennai 9
Norwalk 9
Simi Valley 9
Xian 9
Rehovot 8
San Francisco 8
Vienna 8
Bari 7
Berlin 7
Bethesda 7
Boardman 7
Copenhagen 7
Fuzhou 7
Genoa 7
Krakow 7
Lyngby 7
Madrid 7
Manchester 7
Nanning 7
Oslo 7
Seoul 7
Shenzhen 7
Wenzhou 7
Antwerpen 6
Bandar Seri Begawan 6
Birmingham 6
Brookline 6
Grafing 6
Hebei 6
Hyderabad 6
Irvine 6
Totale 3.118
Nome #
Inactivation of DNA repair triggers neoantigen generation and impairs tumour growth 1.658
Discovery of methylated circulating DNA biomarkers for comprehensive non-invasive monitoring of treatment response in metastatic colorectal cancer 1.044
A Genomic Analysis Workflow for Colorectal Cancer Precision Oncology 538
Digital PCR assessment of MGMT promoter methylation coupled with reduced protein expression optimises prediction of response to alkylating agents in metastatic colorectal cancer patients 537
Refining the selection of patients with metastatic colorectal cancer for treatment with temozolomide using proteomic analysis of O6-methylguanine-DNA-methyltransferase 522
MGMT methylation assessed by methyl-BEAMing technique is a prognostic and predictive biomarker in glioblastoma and metastatic colorectal cancer patients 346
BRAF V600E is a determinant of sensitivity to proteasome inhibitors. 254
Temozolomide treatment alters mismatch repair and boosts mutational burden in tumor and blood of colorectal cancer patients 207
Evolving neoantigen profiles in colorectal cancers with DNA repair defects 194
Molecular landscape of acquired resistance to targeted therapy combinations in BRAF mutant colorectal cancer 189
Colorectal cancer early methylation alterations affect the crosstalk between cell and surrounding environment, tracing a biomarker signature specific for this tumor 147
Digital PCR quantification of MGMT methylation refines prediction of clinical benefit from alkylating agents in glioblastoma and metastatic colorectal cancer 139
MET-driven resistance to dual EGFR and BRAF blockade may be overcome by switching from EGFR to MET inhibition in BRAF mutated colorectal cancer 107
Tumor MGMT promoter hypermethylation changes over time limit temozolomide efficacy in a phase II trial for metastatic colorectal cancer 106
High Circulating Methylated DNA Is a Negative Predictive and Prognostic Marker in Metastatic Colorectal Cancer Patients Treated With Regorafenib. 93
Temozolomide drives mismatch repair deficiency and fosters neoantigen generation in tumor cells 62
Circulating methylated DNA to monitor the dynamics of RAS mutation clearance in plasma from metastatic colorectal cancer patients 54
Ras Mutations in Cancer 52
Capecitabine and Temozolomide versus FOLFIRI in RAS-Mutated, MGMT-Methylated Metastatic Colorectal Cancer 48
Temozolomide and irinotecan (TEMIRI regimen) as salvage treatment of irinotecan-sensitive advanced colorectal cancer patients bearing MGMT methylation 47
Whole exome sequencing analysis of urine trans-renal tumour DNA in metastatic colorectal cancer patients 41
True conversions from RAS mutant to RAS wild-type in circulating tumor DNA from metastatic colorectal cancer patients as assessed by methylation and mutational signature 28
Liquid biopsy of cerebrospinal fluid enables selective profiling of glioma molecular subtypes at first clinical presentation 10
Preclinical efficacy of carfilzomib in BRAF-mutant colorectal cancer models 3
Totale 6.426
Categoria #
all - tutte 11.400
article - articoli 0
book - libri 0
conference - conferenze 261
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.661


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019164 0 0 0 0 0 0 0 0 0 0 110 54
2019/2020782 47 60 79 66 44 55 53 73 95 94 72 44
2020/20211.023 47 43 52 75 104 85 93 63 95 130 87 149
2021/20221.135 134 138 120 159 67 56 64 54 71 48 123 101
2022/20231.444 67 72 51 94 68 135 68 89 593 63 71 73
2023/2024741 79 83 66 58 82 69 94 87 27 88 8 0
Totale 6.426